Insider · CIK 0001779978

Tipirneni Praveen P.

Reports to the SEC for 4 companies · SOUTH SAN FRANCISCO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001779978

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-16	BBOTBridgeBio Oncology Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+31.7K sh	—	—	31,675
2026-06-09	TECXTectonic Therapeutic, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+10.2K sh	—	—	10,200
2025-08-26	BBOTBridgeBio Oncology Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+52.3K sh	—	—	52,269
2025-06-09	TECXTectonic Therapeutic, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+10.2K sh	—	—	10,200
2024-08-16	Morphic Holding, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−177K sh	—	—	0
2024-08-16	Morphic Holding, Inc.Restricted Stock UnitD Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−88.5K sh	—	—	0
2024-08-16	Morphic Holding, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−224K sh	—	—	0
2024-08-16	Morphic Holding, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−206K sh	—	—	0
2024-08-16	Morphic Holding, Inc.Restricted Stock UnitD Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−25K sh	—	—	0
2024-08-16	Morphic Holding, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−273K sh	—	—	0
2024-08-16	Morphic Holding, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−340K sh	—	—	0
2024-08-16	Morphic Holding, Inc.U Disposition from Tender	Director, President and CEO	UDisposition from Tender	−42.5K sh	—	—	0
2024-08-16	Morphic Holding, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−205K sh	—	—	0
2024-08-16	Morphic Holding, Inc.Restricted Stock UnitD Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−137K sh	—	—	0
2024-08-16	Morphic Holding, Inc.U Disposition from Tender	Director, President and CEO	UDisposition from Tender	−614K sh	—	—	0
2024-07-08	Morphic Holding, Inc.Employee Stock Option (right to buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−21.6K sh	—	—	339,561
2024-07-08	Morphic Holding, Inc.S Sale	Director, President and CEO	SSale	−21.6K sh	$55.79	−$1.2M	42,460
2024-07-08	Morphic Holding, Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+21.6K sh	$4.32	+$93.1K	64,042
2024-06-20	TECXTectonic Therapeutic, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+11.8K sh	—	—	11,760
2024-06-20	TECXTectonic Therapeutic, Inc.A Award	Director	AAward	+3,037 sh	—	—	3,037
2024-06-20	TECXTectonic Therapeutic, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+12.2K sh	—	—	12,166
2024-01-16	Morphic Holding, Inc.S Sale	Director, President and CEO	SSale	−13.9K sh	$27.49	−$383K	42,013
2024-01-14	Morphic Holding, Inc.Restricted Stock UnitM Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−12.5K sh	—	—	25,000
2024-01-14	Morphic Holding, Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+12.5K sh	—	—	55,936
2024-01-13	Morphic Holding, Inc.Restricted Stock UnitM Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−29.5K sh	—	—	88,500
2024-01-13	Morphic Holding, Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+29.5K sh	—	—	43,436
2024-01-12	Morphic Holding, Inc.Restricted Stock UnitA Award	Director, President and CEO	AAward	+137K sh	—	—	136,800
2024-01-12	Morphic Holding, Inc.Stock Option (right to buy Common Stock)A Award	Director, President and CEO	AAward	+206K sh	—	—	206,400
2023-08-01	Morphic Holding, Inc.Stock Option (right to buy Common Stock)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−3,597 sh	—	—	361,143
2023-08-01	Morphic Holding, Inc.S Sale	Director, President and CEO	SSale	−493 sh	$57.94	−$28.6K	13,936
2023-08-01	Morphic Holding, Inc.S Sale	Director, President and CEO	SSale	−1,638 sh	$57.42	−$94.1K	14,429
2023-08-01	Morphic Holding, Inc.S Sale	Director, President and CEO	SSale	−1,466 sh	$56.32	−$82.6K	16,067
2023-08-01	Morphic Holding, Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+3,597 sh	$4.32	+$15.5K	17,533
2023-07-03	Morphic Holding, Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+3,597 sh	$4.32	+$15.5K	17,533
2023-07-03	Morphic Holding, Inc.Stock Option (right to buy Common Stock)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−3,597 sh	—	—	364,740
2023-07-03	Morphic Holding, Inc.S Sale	Director, President and CEO	SSale	−3,597 sh	$57.04	−$205K	13,936
2023-06-12	Morphic Holding, Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+840 sh	$4.32	+$3,628.8	14,776
2023-06-12	Morphic Holding, Inc.Stock Option (right to buy Common Stock)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−840 sh	—	—	368,337
2023-06-12	Morphic Holding, Inc.S Sale	Director, President and CEO	SSale	−840 sh	$63.01	−$52.9K	13,936
2023-06-01	Morphic Holding, Inc.S Sale	Director, President and CEO	SSale	−1,609 sh	$57.64	−$92.7K	13,936
2023-06-01	Morphic Holding, Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+3,597 sh	$4.32	+$15.5K	17,533
2023-06-01	Morphic Holding, Inc.S Sale	Director, President and CEO	SSale	−1,988 sh	$56.73	−$113K	15,545
2023-06-01	Morphic Holding, Inc.Stock Option (right to buy Common Stock)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−3,597 sh	—	—	369,177
2023-05-03	Morphic Holding, Inc.Stock Option (right to buy Common Stock)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−3,597 sh	—	—	372,774
2023-05-03	Morphic Holding, Inc.S Sale	Director, President and CEO	SSale	−3,597 sh	$51.11	−$184K	13,936
2023-05-03	Morphic Holding, Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+3,597 sh	$4.32	+$15.5K	17,533
2023-04-25	Morphic Holding, Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+25.2K sh	$4.32	+$109K	39,115
2023-04-25	Morphic Holding, Inc.Stock Option (right to buy Common Stock)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−25.2K sh	—	—	376,371
2023-04-25	Morphic Holding, Inc.S Sale	Director, President and CEO	SSale	−25.2K sh	$53.40	−$1.34M	13,936
2023-01-14	Morphic Holding, Inc.Restricted Stock UnitM Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+12.5K sh	—	—	37,500

Recent filings

Accepted (ET)
Jun 184
Tipirneni Praveen P.0001193125-26-276050
SEC(opens sec.gov)
Jun 104
Tipirneni Praveen P.0001779978-26-000003
SEC(opens sec.gov)
Aug 284
Tipirneni Praveen P.0000950170-25-112020
SEC(opens sec.gov)
Jun 114
Tipirneni Praveen P.0001415889-25-016673
SEC(opens sec.gov)
Aug 204
Tipirneni Praveen P.0001415889-24-021762
SEC(opens sec.gov)
Jul 104
Tipirneni Praveen P.0001415889-24-019471
SEC(opens sec.gov)
Jun 244
Tipirneni Praveen P.0001415889-24-017992
SEC(opens sec.gov)

Companies

Address

BRIDGEBIO ONCOLOGY THERAPEUTICS, INC. 256 EAST GRAND AVENUE, SUITE 104

SOUTH SAN FRANCISCO, CA, 94080